Sanofi SNY
NASDAQ SNY
$41.96 +0.99 (+2.42%)
At close: Oct 22, 2026 · 4:00 PM EDT

Sanofi (SNY) Non-Current Assets (2009 - 2026)

Updated

Sanofi (SNY) posted Non-Current Assets of $113.37 billion for the quarter ended Jun 30, 2026, up 13.9% from $99.55 billion a year earlier but down 1.0% from the prior quarter.

Analysis

Sanofi (SNY) Non-Current Assets (2009 - 2026) Analysis & Trends

As of Dec 31, 2025, Sanofi's Non-Current Assets came in at $108.3 billion, up 10.9% from the prior year.

  • Annual Non-Current Assets shows a five-year compound annual growth rate of 3.3% (years ended Dec 2020 to Dec 2025).
  • In prior years, Sanofi's Non-Current Assets was $97.64 billion in the year ended Dec 31, 2024 (-5.8%), $103.62 billion in the year ended Dec 31, 2023 (+6.2%), $97.61 billion in the year ended Dec 31, 2022 (-7.9%) and $106.02 billion in the year ended Dec 31, 2021 (+15.2%).
  • Quarterly Non-Current Assets has run from a low of $92.43 billion in the quarter ended Mar 31, 2025 to a high of $114.57 billion in the quarter ended Mar 31, 2026 over five years.
  • On a year-over-year basis, Non-Current Assets has increased in each of the last three quarters, with growth averaging 8.0% over the last five quarters.
  • The strongest year-over-year quarter for Non-Current Assets in the past five years was the quarter ended Mar 31, 2026, with growth of 23.9%; the weakest was the quarter ended Dec 31, 2022, with a decline of 7.8%.
  • According to Business Quant data, Non-Current Assets for the three prior quarters was $114.57 billion (quarter ended Mar 31, 2026), $111.58 billion (quarter ended Dec 31, 2025) and $111.94 billion (quarter ended Sep 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Eli Lilly 1,140.19 Bn 1,108.77 Bn 19.71 Bn 77.61 Bn
2 Johnson & Johnson 634.59 Bn 554.45 Bn 17.30 Bn 141.07 Bn
3 AbbVie 499.62 Bn 472.73 Bn 12.70 Bn 101.45 Bn
4 Merck 354.90 Bn 309.28 Bn 12.21 Bn 125.00 Mn
5 Novartis Ag 300.00 Bn 263.99 Bn 11.24 Bn 94.68 Bn
6 Astrazeneca 263.32 Bn 237.01 Bn 12.86 Bn 87.87 Bn
7 Amgen 238.09 Bn 193.49 Bn 7.24 Bn 60.68 Bn
8 Gilead Sciences 193.99 Bn 168.19 Bn 6.22 Bn 35.42 Bn
9 Pfizer 170.34 Bn 116.99 Bn 10.94 Bn 159.77 Bn
10 Sanofi 50.49 Bn 17.01 Bn 10.79 Bn 111.41 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 111.41 Bn
Mar 31, 2026 112.15 Bn
Dec 31, 2025 112.60 Bn
Sep 30, 2025 112.33 Bn
Jun 30, 2025 103.13 Bn
Mar 31, 2025 95.11 Bn
Dec 31, 2024 93.87 Bn
Jun 30, 2024 106.74 Bn
Dec 31, 2023 106.03 Bn
Jun 30, 2023 103.37 Bn
Dec 31, 2022 98.73 Bn
Jun 30, 2022 97.34 Bn
Dec 31, 2021 101.46 Bn
Jun 30, 2021 98.46 Bn
Dec 31, 2020 99.17 Bn
Jun 30, 2020 91.03 Bn
Dec 31, 2019 675.05 Mn
Jun 30, 2019 96.93 Bn
Dec 31, 2018 99.25 Bn
Jun 30, 2018 6.26 Bn
API Access

Sanofi Non-Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-assets&ticker=SNY&period=max&api_key=YOUR_API_KEY